Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2005-12-16 · Food and Drug Administration, HHS · Notices

Notices. Notice

299 words·~1 min read·/register/2005/12/16/05-24100·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA 225-05-8000] Memorandum of Understanding Between the United States Food and Drug Administration and the C-Path Institute AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is providing notice of a memorandum of understanding
(MOU)between the United States Food and Drug Administration and the C-Path Institute. The specific purpose of this MOU is to establish an overarching framework for collaboration between the parties. This framework will be based on mutually agreed upon programs and activities in the areas of applied scientific research and training/education to foster the development of new evaluation tools to inform medical product development. The parties shall each leverage its own expertise and resources to facilitate programs of shared interests across the diverse disciplines of therapeutics, biological sciences, engineering and medical devices in building applied research and training/education programs. The appropriate formal agreements will be executed as required by law for any activities that result from this collaboration. DATES: The agreement became effective October 14, 2005. FOR FURTHER INFORMATION CONTACT: *For C-Path Institute* : Raymond L. Woosley, The Critical Path Institute, 4280 N. Campbell Ave., #214, Tucson, AZ 85718, 520-547-3440, FAX: 520-547-3456, e-mail: *rwoosley@c-path.org* . *For The Food and Drug Administration* : Mary I. Poos, Office of External Relations, Food and Drug Administration (HF-10), 5600 Fishers Lane, Rockville, MD 20857, 301-827-2825, FAX: 301-827-3042, e-mail: *mary.poos@fda.gov* . SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the **Federal Register** , the agency is publishing notice of this MOU. Dated: December 7, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. BILLING CODE 4160-01-S EN16DE05.004 EN16DE05.005 EN16DE05.006 EN16DE05.007 [FR Doc. 05-24100 Filed 12-15-05; 8:45 am]
Connectionstraces to 1
Citation graph
cites case law
Notices
Notice
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.